PF 2413873

Drug Profile

PF 2413873

Alternative Names: PF 0243873; PF-02413873; PF-2413873

Latest Information Update: 28 Jan 2010

Price : $50

At a glance

  • Originator Pfizer
  • Class Pyrazoles
  • Mechanism of Action Progesterone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Endometriosis

Most Recent Events

  • 27 Jan 2010 Discontinued - Phase-I for Endometriosis in Belgium (PO)
  • 27 Jan 2010 Discontinued - Phase-I for Endometriosis in USA (PO)
  • 28 Nov 2008 Phase-I clinical trials in Endometriosis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top